Related Experiment Video

Updated: Jun 21, 2026

Multiomics Analysis of TMEM200A as a Pan-Cancer Biomarker
07:47

Multiomics Analysis of TMEM200A as a Pan-Cancer Biomarker

Published on: September 15, 2023

Cytokine signalling via gp130 in gastric cancer

M Howlett1, T R Menheniott, L M Judd

  • 1Murdoch Childrens Research Institute, Royal Childrens Hospital, Parkville, 3050, Australia.

Biochimica Et Biophysica Acta
|August 12, 2009
PubMed

Insights

Interleukin-11 (IL-11) signaling drives gastric cancer by activating STAT3 and suppressing tumor suppressors. Inhibiting IL-11 or STAT3 may offer new therapeutic strategies for this epithelial cancer.

Area of Science:

  • Oncology
  • Molecular Biology
  • Immunology

Background:

  • gp130-dependent cytokine signaling is crucial in epithelial cancers, including gastric cancer.
  • Dysregulation of these pathways, particularly involving SHP2, MAPK, and STAT3, promotes cancer progression.
  • Interleukin-11 (IL-11) is identified as a primary driver of gp130 signaling in gastric pathology.

Purpose of the Study:

  • To investigate the role of IL-11 and STAT3 in gastric cancer.
  • To explore the impact of Helicobacter pylori infection on these signaling pathways.
  • To assess the potential of targeting IL-11 or STAT3 for cancer therapeutics.

Main Methods:

  • Analysis of cytokine signaling pathways (gp130, MAPK, STAT3) in gastric cancer models.
  • Evaluation of gene expression changes downstream of gp130 signaling.
  • Investigation of IL-11 and STAT3 activation in response to Helicobacter pylori infection.

Main Results:

  • Blockade of SHP2 leads to STAT3 hyperactivation, promoting proliferation, angiogenesis, and inflammation while inhibiting apoptosis.
  • Suppression of key genes like tff1, regulated by MAPK, contributes to gastric tumorigenesis.
  • IL-11 is upregulated in gastric cancer and pre-neoplastic mucosa, with a distinct gene signature observed.
  • Helicobacter pylori infection induces constitutive MAPK activation, STAT3 activation, and increased IL-11 expression.

Conclusions:

  • IL-11 is a key cytokine driving gastric cancer through STAT3 activation.
  • Targeting IL-11 or STAT3 signaling presents a promising therapeutic avenue for gastric cancer.
  • Understanding these pathways is critical for developing novel anti-cancer drugs.

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Gastritis II: Pathophysiology01:26

Gastritis II: Pathophysiology

The pathophysiology of gastritis begins with the colonization of the stomach lining by Helicobacter pylori (H. pylori). This bacterium spreads mainly via the oral-oral route through saliva or shared utensils, and can also be transmitted in overcrowded or unhygienic environments through contaminated water, despite its brief survival outside the body.ColonizationOnce ingested, H. pylori enters the stomach and begins colonization by navigating through the mucus layer lining the stomach wall. It...
GPCRs Regulate Adenylyl Cylase Activity01:09

GPCRs Regulate Adenylyl Cylase Activity

Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of cells.
Two...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...